Shanghai, China Milestone appeared to be the Corporate Investor, which was created in 2014. The company was established in Asia in Pakistan. The main office of represented Corporate Investor is situated in the Lahore.
For fund there is no match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Real Estate Investment, Commercial Real Estate. Among the most popular portfolio startups of the fund, we may highlight 1Token, LenoMed Medical, ImmuneOnco Biopharma.
The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Milestone, startups are often financed by Ufida Happiness Capital, Oriental Fortune Capital, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Zhongchanng Data, Ufida Happiness Capital, Shanghai Momoying Investment Development Center (LP). In the next rounds fund is usually obtained by Zhongchanng Data, Tencent Holdings, TL Ventures.
| Fund Name | Location |
| Apodaca Investments | California, Huntington Beach, United States |
| Astra Ventura | Indonesia, Jakarta, Jakarta Raya |
| Banco Itau | Brazil, São Paulo, Sao Paulo |
| DeNA | Chiyoda, Japan |
| GSM Fund | - |
| International Vitamin | Freehold, New Jersey, United States |
| iRobot Corp | - |
| perceptiveEQUITY | - |
| Redview Capital | China, Hong Kong, Hong Kong Island |
| XL Africa | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
LenoMed Medical | $7M | 10 Dec 2018 | Shanghai, China | ||
| $10M | 19 Nov 2018 | China, Shanghai | |||
TaoData | $15M | 14 Mar 2018 | Shangcheng District, Zhejiang, China | ||
Wemew | $1M | 29 Jun 2017 | Chengdu, Sichuan, China | ||
Xin Xi Bao | 07 Mar 2017 | - | |||
Kangai Gongshe | $1M | 23 Feb 2017 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
LenoMed Medical | $7M | 10 Dec 2018 | Shanghai, China | ||
| $10M | 19 Nov 2018 | China, Shanghai | |||
TaoData | $15M | 14 Mar 2018 | Shangcheng District, Zhejiang, China | ||
Wemew | $1M | 29 Jun 2017 | Chengdu, Sichuan, China | ||
Xin Xi Bao | 07 Mar 2017 | - | |||
Kangai Gongshe | $1M | 23 Feb 2017 | Dongcheng District, Beijing, China |
